Arcadia Biosciences Statistics
Total Valuation
RKDA has a market cap or net worth of $4.99 million. The enterprise value is -$886,843.
Important Dates
The last earnings date was Friday, November 7, 2025, after market close.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RKDA has 1.37 million shares outstanding. The number of shares has increased by 0.28% in one year.
| Current Share Class | 1.37M |
| Shares Outstanding | 1.37M |
| Shares Change (YoY) | +0.28% |
| Shares Change (QoQ) | -47.25% |
| Owned by Insiders (%) | 0.82% |
| Owned by Institutions (%) | 4.77% |
| Float | 1.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.96 |
| Forward PS | 0.67 |
| PB Ratio | 0.91 |
| P/TBV Ratio | 0.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.67
| Current Ratio | 3.67 |
| Quick Ratio | 2.94 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -64.65% and return on invested capital (ROIC) is -47.06%.
| Return on Equity (ROE) | -64.65% |
| Return on Assets (ROA) | -31.48% |
| Return on Invested Capital (ROIC) | -47.06% |
| Return on Capital Employed (ROCE) | -95.25% |
| Revenue Per Employee | $574,778 |
| Profits Per Employee | -$563,000 |
| Employee Count | 9 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.69 |
Taxes
In the past 12 months, RKDA has paid $8,000 in taxes.
| Income Tax | 8,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.78% in the last 52 weeks. The beta is 0.48, so RKDA's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +34.78% |
| 50-Day Moving Average | 3.81 |
| 200-Day Moving Average | 3.90 |
| Relative Strength Index (RSI) | 47.04 |
| Average Volume (20 Days) | 13,414 |
Short Selling Information
The latest short interest is 94,939, so 6.91% of the outstanding shares have been sold short.
| Short Interest | 94,939 |
| Short Previous Month | 130,291 |
| Short % of Shares Out | 6.91% |
| Short % of Float | 6.97% |
| Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, RKDA had revenue of $5.17 million and -$5.07 million in losses. Loss per share was -$3.71.
| Revenue | 5.17M |
| Gross Profit | 2.09M |
| Operating Income | -6.00M |
| Pretax Income | -5.03M |
| Net Income | -5.07M |
| EBITDA | -5.95M |
| EBIT | -6.00M |
| Loss Per Share | -$3.71 |
Full Income Statement Balance Sheet
The company has $5.89 million in cash and n/a in debt, giving a net cash position of $5.89 million or $4.29 per share.
| Cash & Cash Equivalents | 5.89M |
| Total Debt | n/a |
| Net Cash | 5.89M |
| Net Cash Per Share | $4.29 |
| Equity (Book Value) | 5.44M |
| Book Value Per Share | 3.98 |
| Working Capital | 6.10M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -6.09M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.09M |
| FCF Per Share | -$4.43 |
Full Cash Flow Statement Margins
Gross margin is 40.40%, with operating and profit margins of -115.99% and -97.95%.
| Gross Margin | 40.40% |
| Operating Margin | -115.99% |
| Pretax Margin | -97.27% |
| Profit Margin | -97.95% |
| EBITDA Margin | -115.00% |
| EBIT Margin | -115.99% |
| FCF Margin | n/a |